Treatment of Class II Malocclusion With Excessive Overjet

Sponsor
Jenny Kallunki (Other)
Overall Status
Recruiting
CT.gov ID
NCT04508322
Collaborator
Region Östergötland (Other), Malmö University (Other), Eklund foundation Malmö (Other), Swedish Dental Associations Scientific Funds (Other)
120
1
3
167.9
0.7

Study Details

Study Description

Brief Summary

Class II malocclusion with excessive overjet is one of the most common malocclusions among children and adolescents. The overall goal of the project is to analyze orthodontic treatment of Class II malocclusion with excessive overjet when the treatment is started in different ages and treated with removable and/or fixed appliance.

Treatment initiated before the age of eleven is performed with a removable functional appliance, Headgear Activator (HGA). Treatment starting in early adolescence is performed with fixed orthodontic appliance (FA).

The hypotheses are:
  • Treatment with HGA at the age of nine or eleven is effective. No spontaneous correction of the malocclusion is expected in the untreated control group.

  • Patient experience, treatment effect and cost-effectiveness are equivalent whether the treatment with HGA is initiated at the age of nine or eleven.

  • Treatment results, patient experience and treatment- and cost-effectiveness are equivalent whether treatment is initiated early with HGA or initiated in early adolescence with FA.

  • The treatment of Class II malocclusion with excessive overjet renders long-term treatment stability and patient satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Device: HGA
  • Device: FA
N/A

Detailed Description

Participants (children, 9 years of age) are recruited at the orthodontic specialist clinic in Norrköping, Sweden.

After informed consent participants are randomized into Group 1, 2 or 3. After randomization and registration, treatment with HGA is initiated for Group 1.

Group 2 and 3 serves as untreated control group. Two years after registration, Group 2 starts treatment with HGA at the age of eleven.

Group 3 serves as untreated control group to treatment with HGA.

Four years after registration, Group 3 starts treatment with FA (3M Victory brackets, .022 slot size, McLaughlin-Bennet-Trevesi prescription).

The patients in group 1 and 2 in need of a second phase of orthodontic treatment are treated with FA (3M Victory brackets, .022 slot size, McLaughlin-Bennet-Trevesi prescription) in early adolescence.

The following registrations are made:

Study models, photographs (extraoral, intraoral), Lateral head radiographs (T0, T2, T5, if required T1, T3), Child perceptions questionnaire.

T0: After randomization; before treatment start (Group 1), registration/control (Group 2,3).

T1: Two years after T0; after finished treatment for (Group 1), before treatment start (Group 2), control/registration for (Group 3).

T2: Two years after T1; follow up (Group 1), after finished treatment (Group 2), before treatment start (Group 3).

T3: Approx two years after T2 for patients not undergoing treatment with FA. For patients treated with FA, when treatment is finished.

T4: Approx two years after T3- follow up.

T5: Approx 8-10 years after T0 (Long term follow-up)

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Early and Late Treatment of Class II Malocclusion With Excessive Overjet- a Randomized Controlled Trial Regarding Treatment Results, Patient Experience and Treatment and Cost-effectiveness
Actual Study Start Date :
Dec 5, 2013
Anticipated Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Dec 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group 1

Early treatment HGA (9 years)

Device: HGA
Headgear Activator

Device: FA
Fixed Orthodontic Appliance

Active Comparator: Group 2

Late treatment HGA (11 years)

Device: HGA
Headgear Activator

Device: FA
Fixed Orthodontic Appliance

Active Comparator: Group 3

Treatment FA

Device: FA
Fixed Orthodontic Appliance

Outcome Measures

Primary Outcome Measures

  1. Change in overjet; i.e change in tooth position during treatment. Assessment at follow up. [Through study completion (T0-T5), an average of two years between controls.]

    Tooth movement is assessed in millimeters by measures on study models.

Secondary Outcome Measures

  1. Change in Oral health related quality of life (OHRQoL) [Through study completion (T0-T5), an average of two years between controls.]

    Oral health related quality of life is assessed by the use of the Child Perceptions Questionnaire where 0 is minimal and 148 is maximum. Higher scores corresponds to poorer OHRQoL.

  2. Societal costs [During active treatment (T0-T3).]

    Societal costs are the sum of indirect and direct treatment costs. Indirect treatment costs are travel costs for the patient and cost for parents when accompaning patients during treatment. Direct costs are clinical costs due to personnel and material.

  3. Change in tooth position and skeletal growth. [Through study completion (T0-T5), an average of two years between controls.]

    Tooth movement is assessed in millimeters by measures on study models. Skeletal growth is assessed in length and angular measures by cephalometric analysis of lateral radiographs.

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Eight to ten years of age at the start of the trial

  • mixed dentition;

  • Excessive overjet (≥ 6 mm) and first maxillary permanent molars in Class II malocclusion

  • No sucking habits or ceased sucking habits should have been evident at least one year before the trial was started.

Exclusion Criteria:
  • Craniofacial syndromes

  • Previous orthodontic treatment

  • Severe crowding of teeth, i.e. making the extraction of teeth necessary

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Center for Orthodontics and Pedodontics Norrköping Östergötland Sweden 60182

Sponsors and Collaborators

  • Jenny Kallunki
  • Region Östergötland
  • Malmö University
  • Eklund foundation Malmö
  • Swedish Dental Associations Scientific Funds

Investigators

  • Principal Investigator: Jenny Kallunki, Orthodontist, Malmö University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jenny Kallunki, Senior Consultant Orthodontist. PhD-student, Region Östergötland
ClinicalTrials.gov Identifier:
NCT04508322
Other Study ID Numbers:
  • Treatment of Class II maloccl.
First Posted:
Aug 11, 2020
Last Update Posted:
Mar 10, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 10, 2021